- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Immunovia publ AB (IMMNOV)
Immunovia publ AB stock price live, this page displays ST IMMNOV stock exchange data. View the IMMNOV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Immunovia publ AB real time stock price chart below.
What Is the Immunovia publ AB Stock Price Today?
The Immunovia publ AB stock price today is 0.30.
What Is the Stock Symbol for Immunovia publ AB?
The stock symbol for Immunovia publ AB is ""IMMNOV.""
What Stock Exchange Does Immunovia publ AB Trade On?
Immunovia publ AB is listed and trades on the Stockholm stock exchange.
Is Immunovia publ AB a Good Stock to Buy?
Determining whether Immunovia publ AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMMNOV quote. (ISIN: SE0006091997)
What Is the Immunovia publ AB Stock Price Today?
The Immunovia publ AB stock price today is 0.30.
What Is the Stock Symbol for Immunovia publ AB?
The stock symbol for Immunovia publ AB is ""IMMNOV.""
What Stock Exchange Does Immunovia publ AB Trade On?
Immunovia publ AB is listed and trades on the Stockholm stock exchange.
Is Immunovia publ AB a Good Stock to Buy?
Determining whether Immunovia publ AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMMNOV quote. (ISIN: SE0006091997)
Stockholm
Currency in SEK
0.30
+0.04(+15.21%)
Closed·
Fair Value
An estimate of a Immunovia publ AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.26
0.30
52 wk Range
0.24
1.05
Unusual trading volume
1/2
Fair Value
An estimate of a Immunovia publ AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.260.30
52 wk Range
0.241.05
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMMNOV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Immunovia publ AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Immunovia publ AB Company Profile
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Immunovia publ AB Earnings Call Summary for Q3/2025
- Immunovia reported reduced Q3 operating loss of SEK 25.5M (vs SEK 31.2M YoY) with stock rising 5.26% following strategic shift to commercialization of PancreaSure test
- Company secured SEK 100M+ through rights issue, bolstering cash position to SEK 26.6M with runway expected to extend into Q3 2026; monthly cash burn projected at SEK 8-10M
- PancreaSure test for early pancreatic cancer detection launched in September, already adopted by 10 leading cancer centers with pricing ranging from $0-$995
- Company aims to secure Medicare reimbursement by 2026, with test code and rate already established at $897; pursuing additional clinical utility studies
- Management exploring commercial partnerships to enhance market reach while addressing challenges of market penetration in pancreatic cancer screening
Last Updated: 26/11/2025, 15:58
Read Full TranscriptCompare IMMNOV to Peers and Sector
Metrics to compare | IMMNOV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMMNOVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.6x | −12.5x | −0.6x | |
PEG Ratio | −0.02 | −0.16 | 0.00 | |
Price/Book | −24.4x | 2.2x | 2.6x | |
Price / LTM Sales | 256.7x | 4.9x | 3.3x | |
Upside (Analyst Target) | 143.3% | 0.0% | 38.7% | |
Fair Value Upside | Unlock | 14.0% | 3.2% | Unlock |
Earnings
Latest Release
Nov 26, 2025
EPS / Forecast
-0.0467 / -0.08
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Immunovia publ AB Trade On?
Immunovia publ AB is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Immunovia publ AB?
The stock symbol for Immunovia publ AB is "IMMNOV."
What Is the Immunovia publ AB Market Cap?
As of today, Immunovia publ AB market cap is 202.47M.
What Is Immunovia publ AB's Earnings Per Share (TTM)?
The Immunovia publ AB EPS (TTM) is -0.51.
When Is the Next Immunovia publ AB Earnings Date?
Immunovia publ AB will release its next earnings report on 23 Feb 2026.
From a Technical Analysis Perspective, Is IMMNOV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Immunovia publ AB Stock Split?
Immunovia publ AB has split 1 times.
How Many Employees Does Immunovia publ AB Have?
Immunovia publ AB has 12 employees.
What is the current trading status of Immunovia publ AB (IMMNOV)?
As of 29 Nov 2025, Immunovia publ AB (IMMNOV) is trading at a price of 0.30, with a previous close of 0.26. The stock has fluctuated within a day range of 0.26 to 0.30, while its 52-week range spans from 0.24 to 1.05.
What Is Immunovia publ AB (IMMNOV) Price Target According to Analysts?
The average 12-month price target for Immunovia publ AB is SEK0.73, with a high estimate of SEK0.73 and a low estimate of SEK0.73. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +143.33% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.